In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV

Author: Garrison M.W.   Schimmels J.A.   Madaras-Kelly K.J.  

Publisher: Elsevier

ISSN: 0732-8893

Source: Diagnostic Microbiology and Infectious Disease, Vol.47, Iss.4, 2003-12, pp. : 587-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content